Biotech giant Regeneron Pharmaceuticals, Inc. REGN is slated to report first-quarter 2025 results on April 29, 2025. The ...

The PD-L1 IHC 22C3 PharmDx (Code SK006) assay is now certified for use to aid treatment decisions for patients with gastric or gastroesophageal junction adenocarcinoma.

Regeneron's oncology platform is poised to be a significant growth driver in the next decade. Read why REGN stock remains a ...

Medpace MEDP shares ended the last trading session 9.1% higher at $302.56. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session.

China on Wednesday raised additional tariffs on all US imports to 84%, further escalating the trade war with Washington with no immediate relief in sight, after US President Donald Trump launched ...

AbbVie noted that Rinvoq is the first and only oral JAK inhibitor approved in the European Union (EU), as well as Iceland, Liechtenstein and Norway, for the treatment of adult patients with GCA, and ...

According to prior statements 2 by Regeneron, the companies are also seeking approval from the US Food and Drug Administration for the third indication of aflibercept 8 mg. Harp MD. Regeneron ...

J&J has filed a supplemental biologics licence application with the US Food and Drug Administration for a new indication for daratumumab SC with VRd. Credit: josefkubes/Shutterstock. The European ...

He has done it all in his 40 years at UConn, and amid the celebration of his latest championship gave no indication that he’s slowing down just yet. “We don’t like to admit that we’re ...

He won his 12th NCAA title, 30 years after winning his first one. He has done it all in his 40 years at UConn, and amid the celebration of his latest championship gave no indication that he’s slowing ...